EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma

Fauzia Jamal iD, Ghufran Ahmed, Mohammad Farazuddin, Ishrat Altaf, Saba Farheen, Qamar Zia iD, Asim Azhar iD, Hira Ahmad, Aijaz Ahmed Khan, Satyanarayana Somavarapu, Anshu Agrawal, Mohammad Owais

Molecules · 2023

DOI: 10.3390/molecules28052191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Fauzia Jamal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Biotechnology Unit (IBU), Aligarh Muslim University, Aligarh 202002, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutics, based on small interfering RNA (siRNA), have demonstrated tremendous potential for treating cancer. However, issues such as non-specific targeting, premature degradation, and the intrinsic toxicity of the siRNA, have to be solved before they are ready for use in translational medicines. To address these challenges, nanotechnology-based tools might help to shield siRNA and ensure its specific delivery to the target site. Besides playing a crucial role in prostaglandin synthesis, the cyclo-oxygenase-2 (COX-2) enzyme has been reported to mediate carcinogenesis in various types of cancer, including hepatocellular carcinoma (HCC). We encapsulated COX-2-specific siRNA in Bacillus subtilis membrane lipid-based liposomes (subtilosomes) and evaluated their potential in the treatment of diethylnitrosamine (DEN)-induced hepatocellular carcinoma. Our findings suggested that the subtilosome-based formulation was stable, releasing COX-2 siRNA in a sustained manner, and has the potential to abruptly release encapsulated material at acidic pH. The fusogenic property of subtilosomes was revealed by FRET, fluorescence dequenching, content-mixing assay, etc. The subtilosome-based siRNA formulation was successful in inhibiting TNF-α expression in the experimental animals. The apoptosis study indicated that the subtilosomized siRNA inhibits DEN-induced carcinogenesis more effectively than free siRNA. The as-developed formulation also suppressed COX-2 expression, which in turn up-regulated the expression of wild-type p53 and Bax on one hand and down-regulated Bcl-2 expression on the other. The survival data established the increased efficacy of subtilosome-encapsulated COX-2 siRNA against hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAnimalsDiethylnitrosamineRNA, Small InterferingCyclooxygenase 2ApoptosisCarcinogenesis

Stichwörter der Autor:innen

COX-2apoptosishepatocellular carcinomasiRNAsubtilosome

Substanzen

DiethylnitrosamineRNA, Small InterferingCyclooxygenase 2

Autor:innen und Institutionen

  • Interdisciplinary Biotechnology Unit (IBU), Aligarh Muslim University, Aligarh 202002, India.
  • Division of Microbiology, ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.
  • Mary H. Weiser Food Allergy Center, University of Michigan, Ann Arbor, MI 48109-1316, USA.
  • Health and Basic Science Research Centre, Majmaah University, Majmaah 11952, Saudi Arabia.
  • Neat Meatt Biotech Private Limited, Bio-NEST-UDSC, University of Delhi (South Campus), New Delhi 110021, India.
  • Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.

ORCID-Profile: Fauzia Jamal, Qamar Zia, Asim Azhar

Zitieren

APA

Jamal, F., Ahmed, G., Farazuddin, M., Altaf, I., Farheen, S., Zia, Q., Azhar, A., Ahmad, H., Khan, A. A., Somavarapu, S., Agrawal, A., & Owais, M. (2023). Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma. Molecules. https://doi.org/10.3390/molecules28052191

Vancouver

Jamal F, Ahmed G, Farazuddin M, Altaf I, Farheen S, Zia Q, et al. Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma. Molecules. 2023. doi:10.3390/molecules28052191

BibTeX
@article{Jamal2023,
  author = {Jamal, Fauzia and Ahmed, Ghufran and Farazuddin, Mohammad and Altaf, Ishrat and Farheen, Saba and Zia, Qamar and Azhar, Asim and Ahmad, Hira and Khan, Aijaz Ahmed and Somavarapu, Satyanarayana and Agrawal, Anshu and Owais, Mohammad},
  title = {Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28052191}
}
Kostenlos starten →